6505--Compounded Chemotherapy Drugs

Closed Solicitation Posted

Solicitation number
36C26221Q1279
Agency
Responses due
Set-aside
No set-aside

Opportunity facts

Place of performance
Department of Veteran Affairs VA Long Beach Healthcare System Long Beach CA 90822, United States

Notice details come from SAM.gov. Updated .

About this opportunity

The Department of Veterans Affairs, Veterans Integrated Service Network 22 is seeking quotes from qualified vendors to provide compounded chemotherapy medications to the VA Long Beach Healthcare System pharmacy from October 1, 2021 through September 30, 2022. The solicitation lists over 200 chemotherapy and supportive drugs that the VA seeks to procure on an as-needed basis to serve approximately 30 patients daily. Quotes are due by September 15, 2021 and must include fixed pricing for estimated weekly drug costs, shipping fees, and per-patient order fees. Award will be made to the responsive, responsible offeror providing the lowest total price that meets all technical requirements.

This requirement has no set-aside designation. The primary NAICS code is 325412 for pharmaceutical preparation manufacturing with a small business size standard of 1250 employees. Quotes must include the vendor's small business size and DUNS number. The place of performance is the VA Long Beach Healthcare System located at 5901 E 7th Street, Long Beach, CA 90822, where the awarded vendor must deliver compounded chemotherapy medications by the patient's infusion date via FedEx to serve a minimum of 30 patients daily through September 2022.

Notice text

Page 12 of 12

Description

This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Federal Acquisition Regulation (FAR) subpart 12.6, Streamlined Procedures for Evaluation and Solicitation for Commercial Items, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; quotes are being requested and a written solicitation will not be issued. This is a request for quotes under solicitation number: 36C26221Q1279

The associated North American Industrial Classification System (NAICS) code for this procurement is 325412 with a small business size standard of 1250 employees

The FSC/PSC is 6505.

The Department of Veterans Affairs (VA), VISN 22 Network Contracting Office, is seeking sources that can provide the COMPOUNDED CHEMOTHERAPY MEDICATIONS for the VA Long Beach Healthcare System, Pharmacy Service, 5901 E. 7th Street, Long Beach, CA 90822.

All interested companies shall provide must be able to provide entire list of compounded chemotherapy medications on an as needed basis and on the terms and conditions stated within the statement of work.

Supplies/Services:

List of Compounded Chemotherapy Medications

There will be approximately (30) thirty patients on any given day, Monday through Friday for chemotherapy infusion for 52 weeks. Below is a list of the common chemotherapy drugs will be provided directly to the vendor. Must be able to supply and deliver all compounded chemotherapy medications listed below. Orders are based on need for each patient. Please include the temperature logger in shipments to monitor temperature of drugs for quality assurance. Shipping fees must be inclusive (cost per week) within the hazardous compounded chemotherapy drug. **Please see Statement of Work for other instructions.

ITEM NUMBER

DESCRIPTION OF SUPPLIES/SERVICES

QUANTITY

UNIT

UNIT PRICE

AMOUNT

0001

52.00

WK

Estimated cost of compounded Chemotherapy when VA purchases drugs through the vendor (includes *Special Fees*) (Cost per week)

0002

52.00

WK

Estimated Shipping fees (Cost Per Week)

0003

52.00

WK

Per patient order fee

GRAND TOTAL

**All orders are based as needed basis.

The period of performance is October 1, 2021 to September 30, 2022.

Generic Name

Brand Name

Abatacept

Orencia 125mg 4/box

Abatacept

Orencia 250mg

Abatacept

Orencia Click-Jet 125mg 4/box

Abobotulinumtoxin A

Dysport 500u

Adalimumab

Humira 40mg/0.8ml Pen 2/box

Ado-trastuzumab emtansine

Kadcyla 100mg/15ml

Ado-trastuzumab emtansine

Kadcyla 160mg/20ml

Aflibercept

Eylea 2mg

Alteplase

Cathflo Activase 2mg

Amifostine

Amifostine 500mg via-l 3/bx

Amikacin

Amikacin Sulfate PF 500mg/2ml 10/box

Amphotericin B

Amphotericin B 50mg

Arginine

R-Gene HCL 300ml

Aripiprazole

Ability Maintena 400mg Syringe

Arsenic

Trisenox 10mg 10/box

Arsenic

Trisenox 12mg 10/box

Asparaginase Erwinia

Erwinaze 10,000iu/vi - Svl/box

Atezoliumab

Tecentriq 60mg/ml 20ml

Atropine

Atropine 0.4mg/ml 25/box

Atropine

Atropine 1mg syringe 10/box

Atropine

Atropine lmg/ml 25/box

Avelumab

Bavencio 20mg/ml 10ml

Azacitidine

Azacitidine 100mg

Bacteriostatic Water

Bacteriostatic Water 30ml 25/box

BCG LIVE

TICE BCG 50mg

Belimumab

Benlysta 120mg

Belimumab

Benlysta 400mg

Bendamustine

Belrapzo (Eagle brand) 100mg

Bendamustine

Bendeka 100mg

Bendamustine

Treanda 100mg PWD

Bendamustine

Treanda 25mg PWD

Benralizumab

Fasenra 30mg Syr

Bevacizumab

Avastin 100mg

Bevacizumab

Avastin 400mg

Bevacizumab-AWWB

Mvasi 100mg

Bevacizumab-AWWB

Mvasi 400mg

Bevacizumab-BVZR

Zirabev 100mg

Bevacizumab-BVZR

Zirabev 400mg

Bezlotoxumab

Zinplava 1000mg

Bleomycin

Bleomycin 15u

Blinatumomab

Blincyto 35mcg

Bortezomib

Velcade 3.5mg

Brentuximab Vedotin

Adcetris 50mg

Cabazitaxel

Jevtana 60mg

Calcium Gluconate

Calcium Gluc 100mg 10% 10ml 25/box

Calcium Gluconate

Calcium Gluconate 10% 50ml 25/box

Carboplatin

Carboplatin 150mg

Carboplatin

Carboplatin 450mg

Carboplatin

Carboplatin 50mg

Carboplatin

Carboplatin 600mg

Carfilzomib

Kyprolis 30mg

Carfilzomib

Kyprolis 60mg

Carmustine

BicNu 100mg

Carmustine in Polifeprosan

Gliadel Wafer

Cefazolin

Cefazolin 1gm 25/box

Cefepime

Cefepime 1gm 10/box

Ceftazidime

Ceftazidime 2gm 10/box

Ceftazidime

Tazicef 1gm 25/box

Ceftriaxone

Ceftriaxone 1 gm 10/box

Certolizumab

Cimzia 200mg Syr 2/box

Cetuximab

Erbitux 100mg

Cidofovir

Cidofovir

Cisplatin

Cisplatin 100mg

Cisplatin

Cisplatin 50mg

Cladribine

Cladribine 10mg

Clindamycin

Clindamycin 300mg/50ml ea.

Clindamycin

Clindamycin 600mg/4ml ea.

Clofarabine

Clolar 20mg

Collagenase Clostridium Hist

Xiaflex 0.9mg vial

Cyanocobalamin

Cyanocobalamin 1000mcg/1ml 25/box

Cyclophosphamide

Cyclophosphamide 1gm

Cyclophosphamide

Cyclophosphamide 1gm

Cyclophosphamide

Cyclophosphamide 25mg (100 tabs)

Cyclophosphamide

Cyclophosphamide 2gm

Cyclophosphamide

Cyclophosphamide 500mg

Cyclophosphamide

Cyclophosphamide 50mg (100 tabs)

Cyclosporine

Cyclosporine 250mg/5ml 10/box

Cytarabine

Cytarabine 100mg 5/box

Cytarabine

Cytarabine 2gm

Cytarabine Liposomal

Depocyt 50mg

Dacarbazine

Dacarbazine 200mg 10/box

Dactinomycin

Cosmegen 0.5mg

Daratumumab

Darzalex 100MG

Daratumumab

Darzalex 400MG

Daunorubicin

Daunorubicin 20mg/4mL 10/box

Decitabine

Dacogen 50mg

Deferoxamine

Deferoxamine 500mg 4/box

Degarelix

Firmagon 240mg (2 x120)

Degarelix

Firmagon 80mg

Denosumab

Prolia 60mg

Denosumab

Xgeva 120mg

Dexamethasone

Dexamethasone 10mg/mL 10mL 10/box

Dexamethasone

Dexamethasone 10mg/ml 1ml 25/box

Dexamethasone

Dexamethasone 4mg/ml 1ml 25/box

Dexamethasone

Ozurdex Implant 0.7mg Kit (DS item 1-2 days)

Dexrazoxane

Zinecard (Dexrazoxane) 500mg

Diphenhydramine

Diphenhydramine 50mg 25/box

Docetaxel

Docetaxel 160mg/8ml (20mg/ml)

Docetaxel

Docetaxel 20mg/2ml (10mg/mL)

Docetaxel

Docetaxel 80mg/8ml (10mg/mL)

Doxorubicin

Adriamycin 50mg

Doxorubicin

Doxorubicin 10mg 10/box

Doxorubicin

Doxorubicin 20mg

Doxorubicin

Doxorubicin 50mg

Doxorubicin

Doxorubicin 50mg

Durvalumab

Imfinzi 120mg

Durvalumab

Imfinzi 500mg

Eculizumab

Soliris 300mg

Enfortumab Vedotin EJFV

Padcev 30mg

Ep9etin

Epogen 10k unit 10/box

Epinepherine

Epinepherine 1:1000 25/box

Epinepherine

Epinepherine 30mg vial

Epirubicin

Epirubicin 200mg

Epirubicin

Epirubicin 50mg

Epoetin

Epogen 20k unit 10/box

Epoetin

Epogen 4k unit 10/box

Epoetin

Procrit 10k unit 6/box

Epoetin

Procrit 20k unit 4/box

Epoetin

Procrit 40k unit 4/box

Epoetin

Procrit 4k unit 6/box

Epoetin Alfa EPBX

Retacrit 10k unit 10/box

Epoetin Alfa EPBX

Retacrit 40k unit 4/box

Eribulin Mesylate

Halaven 1mg

Ertapenem

lnvanz 1gm 10/box

Etanercept

Enbrel Mini 50mg/0.98ml Cart

Etoposide

Etoposide 100mg

Etoposide

Etoposide 1gm

Etoposide

Etoposide 500mg

Famotidine

Famotidine 20mg 25/box

FAM-Trastuzumab-Deruxtecn-nxkiFAM

Enhertu 100mg pwd

Ferric Carboxymaltose

Injectafer 750mg

Ferric Gluconate

Ferric Gluconate 62.5mg 10/box

Ferumoxytol

Feraheme 510mg

Filgrastim

Neupogen 300mcg syringe 10/box

Filgrastim

Neupogen 480mcg syringe 10/box

Filgrastim AAFI 480mcg/0.8ml Syr each

Nivestym 480mcg/0.8ml Syr each

Filgrastim-Sndz

Zarxio 300mcg syringe ea.

Filgrastim-Sndz

Zarxio 480mcg syringe ea.

Floxuradine

Floxuradine 500mg

Fludarabine

Fludarabine 50mg

Fluorouracil

Fluorouracil 1gm 10/box

Fluorouracil

Fluorouracil 2.5gm

Fluorouracil

Fluorouracil 500mg 10/box

Fluorouracil

Fluorouracil 5gm

Fosaprepitant

Emend 150mg

Foscarnet Sodium

Foscavir Ggm 10/box

Fulvestrant

Faslodex 250mg 2/box

Furosemide

Furosemide 100mg vial 25/box

Furosemide

Furosemide 20mg 25/box

Ganciclovir

Ganciclovir 500mg (Cytovene) 25/box

Gemcitabine

Gemcitabine 1gm

Gemcitabine

Gemcitabine 1gm (100mg/ml 10ml)

Gemcitabine

Gemcitabine 200mg

Gemcitabine

Gemcitabine 200mg (100mg/ml 2ml)

Gemcitabine

Gemcitabine 2gm

Gemtuzumab Ozogamicin

Mylotarg 4.5mg

Gentamicin Sulfate

Gentamicin 80mg 25/box

Golimumab

Simponi Aria 12.5mg/ml 4ml

Granisetron

Granisetron Hydrochloride 1mg

Granisetron

Granisetron Hydrochloride 4mg

Heparin Sodium

Heparin Sodium 1000u/ml 1ml 25/box

Hyaluronate Sodium

Euflexxa 1% 20mg/2ml (20mg) syringe 3x2ml

Hyaluronate Sodium

Gel-One 30mg/3ml Syringe

Hyaluronate Sodium

Gelsyn-3, 8.4mg/ml 2ml syringe

Hyaluronate Sodium

Hyalgan 20mg/2ml syringe

Hyaluronate Sodium

Monovisc 22mg/ml 4ml Syringe

Hyaluronate Sodium

Orthovisc 30mg/2ml Syringe

Hyaluronate Sodium

Supartz 25mg/2.5ml Syringe

Hyaluronate Sodium

Synvisc 16mg/2ml 3x2ml Syringe

Hyaluronate Sodium

Synvisc-One 48mg/6ml Syringe

Hyaluronate Sodium

Visco-3 10mg/ml 3x 2.5ml Syringe

Hydrocortisone

Solu-Cortef 100mg

Idarubicin

Idarubicin 10mg

Idarubicin

Idarubicin 20mg

Idarubicin

Idarubicin 5mg

Ifosfamide

Ifosfamide 1gm

Immune Globulin IVIG

Octagam 10% 10gm

Immune Globulin IVIG

Octagam 10% 20gm

Immune Globulin IVIG

Octagam 10% 2gm

Immune Globulin IVIG

Octagam 10% 5gm

Incobotulinumtoxin A

Xeomin PR 200u PF

Infliximab

Remicade 100mg

Infliximab-ABDA

Renflexis 100mg

Infliximab-DYYB

lnflectra 100mg

Interferon alfa 2-b

lntron A l0mu

Iohexal

Omnipaque 300mg/50ml 10/box

Iopamidol

lsovue-300mg 61% 10x30ml

Ipilimumab

Yervoy 200mg

Ipilimumab

Yervoy 50mg

Irinotecan

Irinotecan 100mg

Irinotecan

Irinotecan 40mg

Iron Dextran

Infed 100mg 10/box

Iron Sucrose

Venofer 100mg 10/box

Iron Sucrose

Venofer 200mg 5/box

IVIG

·Gamma gard 1gm vial

IVIG

Atgam S0mg/ml SxSml amp

IVIG

Carimune 12gm

IVIG

Carimune 6gm

IVIG

Gammagard 20gm vial

IVIG

Gammagard 5gm vial

IVIG

Gammagard 10gm vial

IVIG

Gammaked 10gm

IVIG

Gammaked 1gm

IVIG

Gammaked 2.5gm

IVIG

Gammaked 20gm

IVIG

Gammaked 5gm

LC BEADS

100-300um 2ml

LC BEADS

300-500um 2ml

LC BEADS

70-150um 2ml

Leucovorin

Leucovorin 100mg

Leucovorin

Leucovorin 350mg

Leuprolide Acetate

Eligard 22.5mg

Leuprolide Acetate

Eligard 30mg

Leuprolide Acetate

Eligard 45mg

Leuprolide Acetate

Eligard 7.5mg

Leuprolide Acetate

Leuprolide 14mg 2.8ml 14 day kit

Leuprolide Acetate

Lupron Depot 11.25mg

Leuprolide Acetate

Lupron Depot 3.75mg

Levoleucovorin

Fusilev 50mg

Lidocaine

Lidocaine 4% 40mg/ml 25x5ml

Liposomal Doxorubicin

Liposomal Doxorubicin 20mg

Liposomal Doxorubicin

Liposomal Doxorubicin 50mg

Liposomal Irinotecan

Onivyde 4.3mg/ml 10ml

Lorazepam

Lorazepam 2mg/1mL 10/box

Lurbinectedin

Zepzelca 4mg

Magnesium Sulfate

Magnesium Sulfate 1gm/2mL 25/box

Mannitol

Mannitol 25% 50mL each 25/box

Mechlorethamine

Mechlorethamine 10mg 4/box

Melphalan

Alkeran 50mg

Mepolizumab

Nucala 100mg

Mesna

Mesna 1gm

Methotrexate

Methotrexate 50mg PF 10/box

Methotrexate

Methotrexate PF 1gm

Methotrexate

Methotrexate PF 250mg 10ml

Methylene Blue

Provayblue 0.5% Sx10ml

Methylprednisolone

Solu-Medrol (A-Methapred) 125mg 25/box

Methylprednisolone

Solu-Medrol (Methylprednisolone 40mg) x25

Metoclopramide

Metoclopramide 10mg 25/box

Mitomycin

Mitomycin 20mg

Mitomycin

Mitomycin 40mg

Mitomycin

Mitomycin 5mg

Mitoxantrone

Novantrone 20mg

Mitoxantrone

Novantrone 25mg

Mycophenolate Mofetil

Cellcept 500mg 4x20ml

Naltrexone

Vivitrol 380mg

Natalizumab

Tysabri 300mg

Nelarabine

Arranon SF 250mg 6/box

Nivolumab

Opdivo 100mg/10ml SDPF

Nivolumab

Opdivo 240mg/10ml SDPF

Nivolumab

Opdivo 40mg/4ml SDPF

Normal Saline

0.9% NACL 50ml 25/box

Obinutuzumab

Gazyva 1000mg/40ml SDV PF

Ocrelizumab

Ocrevus 300mg

Octreotide

Octreotide 100mcg 10/box

Octreotide

Sandostatin LAR 10mg

Octreotide

Sandostatin LAR 20mg

Octreotide

Sandostatin LAR 30mg

Ofatumumab

Arzerra 20mg/ml 3x5ml '

Ofatumumab

Arzerra 20mg/ml lxS0ml

Omalizumab

Xolair 150mg Syringe

Omalizumab

Xolair 75mg Syringe

Onabotulinumtoxina

Botox 100iu (drop ship - dr info req)

Oncozene Beads

100mcm

Ondansetron

Ondansetron 40mg

Ondansetron

Ondansetron 4mg 25/box

Oxaliplatin

Oxaliplatin 100mg

Oxaliplatin

Oxaliplatin 50mg

Paclitaxel

Paclitaxel 100mg

Paclitaxel

Paclitaxel 300mg

Paclitaxel

Paclitaxel 30mg

Palifermin

Kepivance 6.25mg/ml 3/box

Palonosetron

Palonosetron 0.25mg

Pamidronate

Pamidronate 30mg

Pamidronate

Pamidronate 90mg

Panitumumab

Vectibix 100

Panitumumab

Vectibix 400

PB Paclitaxel

Abraxane 100mg

Pegasparaginase

Oncaspar 3,750 units

Pegfilgrastim

Fulphila 6mg/0.6ml syringe

Pegfilgrastim

Neulasta 6mg syringe

Pegfilgrastim

Neulasta Onpro Delivery Kit 6mg

Pegfilgrastim

Udenyca 6mg/0.6ml syringe

Pembrolizumab

Keytruda 100mg

Pembrolizumab

Keytruda 100mg x2

Pemetrexed

Alimta 100mg

Pemetrexed

Alimta 500mg

Pentamidine Isethionate

Pentam 300mg 10/box

Pentamidine lsethionate

Nebupent 300mg

Pentostatin

Nipent 10mg

Pertuzumab

Perjeta 420mg

Polatuzumab Vedotin-PIIQ

Polivy 30mg

Potassium

Potassium Chloride 20meq 25/box

Pralatrexate

Folotyn 20mg

Pralatrexate

Folotyn 40mg

Prochlorperazine

Prochlorperazine Edisylate 10mg 10/box

Promethazine

Promethazine 25mg 25/box

Ramucirumab

Cyramza 100mg

Ramucirumab

Cyramza 500mg

Ranibizumab

Lucentis .3mg/.05ml vial

Ranibizumab

Lucentis .5mg/.0SmL vial

Ranitidine

Ranitidine 50mg/2ml 10/box

Rasburicase

Elitek 1.5mg 3/box

Rasburicase

Elitek 7.5mg vial

Rimabotulinumtoxinb

Myobloc 5000u/ml 1ml

Risankizumab-RZAA

Skyrizi 75mg/0.83ml

Rituximab

Rituxan 100mg

Rituximab

Rituxan 500mg

Rituximab-ABBS

Truxima 100mg

Rituximab-ABBS

Truxima 500mg

Rituximab-PVVR

Ruxience 100mg

Rituximab-PVVR

Ruxience 500mg

Romidepsin

lstodax 10mg

Romiplostim

Nplate 250mcg

Romiplostim

Nplate 500mcg

Sodium Bicarbonate

Sodium Bicarbonate 8.4% 50ml syr 10/box

Sodium Bicarbonate

Sodium Bicarbonate 8.4% 50meq vial 25/box

Tacrolimus

Prograf 5mg/ml 1ml PF Amp 10/box

Tbo-Filgrastim

Granix 300mcg Syringe x1

Tbo-Filgrastim

Granix 480 mcg Syringe x1

Temsirolimus

Torisel 25mg

Testosterone

Depo-Testosterone 200mg/10ml

Tetracaine

Tetracaine .5% OPHT Sol 12/box

Thiotepa

Thiotepa 15mg

Thyrotropin

Thyrogen 1.1mg x2

Tocilizumab

Actemra 200mg

Tocilizumab

Actemra 400mg

Tocilizumab

Actemra 80mg

Topotecan

Topotecan 4mg

Trabectedin

Yondelis 1mg

Trastuzumab

Herceptin 150mg

Trastuzumab-ANNS

Kanjinti 150mg

Trastuzumab-ANNS·

Kanjinti 420mg

Trastuzumab-QYYP

Trazimera 420mg

Triamcinalone PF

Triesence 40mg/1ml PF

Triptorelin

Trelstar 3.75mg

Ustekinumab

Sterlara 130mg Smg/ml 26ml

Valrubicin

Valstar 40mg/ml 5ml SDV 4/box

Vancomycin

Vancomycin 1gm 10/box

Vedolizumab

Entyvio 300mg 20ml SDV

Vinblastine

Vinblastine 10mg

Vincristine

Vincristine 1mg

Vincristine

Vincristine 2mg

Vinorelbine

Vinorelbine 10mg

Vinorelbine

Vinorelbine 50mg

Water

Sterile Water 10ml 25/box

Water

Sterile Water 50ml 25/box

Ziv-Afilbercept

Zaltrap 100mg

Ziv-Afilbercept

Zaltrap 200mg

Zoledronic Acid

Zoledronic Acid 4mg/5ml (Generic Zometa)

Zoledronic Acid

Zoledronic Acid 5mg (Generic Reclast)

Notice: No remanufactures or gray market items/ supplies will not be acceptable. Interested parties of RFI/RFQ must be an authorized reseller, distributor, or dealer of the O.E.M. (Original Equipment Manufacturer). Verification can be provided by an authorization letter or other documents from the OEM. Equipment shall be in accordance with the OEM terms and conditions. No exceptions. Must be a manufacturer authorized distributor.

Delivery: Upon completion of compounding, medications will be transported VIA FedEx to VA prior to Chemotherapy Infusion Date. Must be able to provide next day delivery. (See Statement of Work for instructions)

Place of Performance/Place of Delivery:

Department of Veterans Affairs

VHA Long Beach Healthcare System

5901 East 7th Street

Long Beach, CA 90822

The full text of FAR provisions or clauses may be accessed electronically at http://acquisition.gov/comp/far/index.html.

The following solicitation provisions apply to this acquisition:

FAR 52.212-1, Instructions to Offerors Commercial Items

ADDENDUM: Applies to this acquisition and the following addenda to the provision.

The Offeror s quotation shall be submitted electronically on company letterhead stationery to the Points of Contact identified in Contract Opportunities combined synopsis/solicitation announcement by the date and time indicated.

As part of your quote submission you are required to include price information. DUNS, Cage Code, tax ID, terms and conditions and Buy American Act Certificate required in clause 252.225-7000, as applicable.

Late submissions Offerors are responsible for submitting at the time specified. An offer received after the time specified is late and will not be considered.

All firms must be registered in SAM at https://www.sam.gov at time of quote submittal in order to be considered for award. Please provide quote expiration date and best delivery schedule.

SUBMISSION OF QUESTIONS

Questions: All questions must be received by 9/09/2021 at 12:00pm Pacific Standard Time (PST). All questions submitted for this solicitation must be electronically sent to the following email address: adrienne.brown4@va.gov. Questions received after the stated date and time, may be addressed at the discretion of the Contracting Officer.

The solicitation will be in accordance with FAR Part 12, 13, and 19, Acquisition of Commercial Items, Simplified Acquisition Procedures, Small Business Programs, and Veteran Affairs Acquisition Regulations as supplemented with additional information in this notice. The North American Industrial Classification System (NAICS) code for this requirement is 325412 Size Standard is 1250 employees. The Contractor shall adhere to all federal and state laws and regulations in effect during the term of this contract. The Government intends to award a firm-fixed-price contract. The Contract begins on the date of award. Due to time constraints, responses to the solicitation shall be due on September 15, 2021 at 06:00 AM PST. NO EXTRA TIME WILL BE GIVEN, Offerors are advised that it is your responsibility to review and monitor the website frequently to ensure you have the most up to date information, including amendments. Offeror shall quote all line items under this requirement and the pricing terms of the quotation shall be valid for at least 90 days unless a longer time is stated in the quote.

Correspondence or questions may be directed to Adrienne Brown at adrienne.brown4@va.gov with 36C26221Q1279 COMPOUNDED CHEMOTHERAPY MEDICATIONS in the subject line within 48 hours of release of this notice. Telephone inquiries will not be honored. Inquiries after the allotted period may not be responded to due to the time constraints of the procurement. All offerors must be registered in www.sam.gov to do business with the Government. Ensure your registration is correct, current and has not expired. Please include your DUNS number on your quote. Also, for verification of your SDVOSB and VOSB, please insured your business is register with the Office of Small and Disadvantage Business Utilization, here is the link: https://www.vip.vetbiz.va.gov/Search/AdvancedSearchForm.

FAR 52.212-3, Offerors Representations and Certifications Commercial Items

Offerors must complete annual representations and certifications electronically via the System for Award Management (SAM) website located at https://www.sam.gov/portal in accordance with FAR 52.212-3, Offerors Representations and Certifications Commercial Items. If paragraph (j) of the provision is applicable, a written submission is required. SAM registration is required to be complete at the time of submission of response. No exceptions.

The following contract clauses apply to this acquisition:

FAR 52.212-1 INSTRUCTIONS TO OFFERORS COMMERCIAL ITEMS (OCT 2018)

FAR 52.212-4, Contract Terms and Conditions Commercial Items

FAR 52.212-5, Contract Terms and Conditions Required to Implement Statutes or Executive Orders-Commercial Items

852.212-71Â Gray Market Items.

852.219-10 VA Notice of Total Service-Disabled Veteran-Owned Small Business Set-Aside

(a) No gray market or remanufactured items will be acceptable. Gray market items are Original Equipment Manufacturers (OEM) goods sold through unauthorized channels in direct competition with authorized distributors. This procurement is for new OEM medical equipment only for VA medical facilities.

(b) Vendor shall be an OEM, authorized dealer, authorized distributor or authorized reseller for the proposed equipment/system, verified by an authorization letter or other documents from the OEM. All software licensing, warranty and service associated with the equipment/system shall be in accordance with the OEM terms and conditions.

(End of clause)

The following subparagraphs of FAR 52.212-5 are applicable:

All quoters shall submit the following: 1) quotes (with company letterhead) listing all requested line items, quantities, unit, unit price, extended price, delivery and installation, in-service training, warranty information, quote expiration date, salesperson/POC contact information. 2) Authorized distributor letters as applicable.

All quotes shall be sent to:

Adrienne Brown, Contract Specialist, NCO 22L.

Email: adrienne.brown4@va.gov

Award will be based upon a comparative evaluation of quotes in accordance with the Simplified Acquisition Procedures of FAR 13. Comparative evaluation is the side by side pairwise comparison of quotes based on factors resulting in a Contracting Officer decision for the quote most favorable to the Government.

The following are the decision factors:

Technical acceptability shall be established by review of each submitted quote, attachments, and/or information by the designated technical evaluator(s) and verification that any brand name or equal to items" at a minimum meet all the salient characteristics outlined in the attach of this solicitation. No other rating or quantitative value other than acceptable or unacceptable will be assigned.

Award will be made to the offer that meets all minimum requirements and provides the lowest price.

The award will be made to the response most advantageous to the Government.

Responses should contain your best terms, conditions.

52.212-1 INSTRUCTIONS TO OFFERORS COMMERCIAL ITEMS (OCT 2018)

(a) North American Industry Classification System (NAICS) code and small business size standard. The NAICS code and small business size standard for this acquisition appear in Block 10 of the solicitation cover sheet (SF 1449). However, the small business size standard for a concern which submits an offer in its own name, but which proposes to furnish an item which it did not itself manufacture, is 500 employees.

(b) Submission of offers. Submit signed and dated offers to the office specified in this solicitation at or before the exact time specified in this solicitation as specified in the solicitation. As a minimum, offers must show

(1) The solicitation number;

(2) The time specified in the solicitation for receipt of offers;

(3) The name, address, and telephone number of the offeror;

(4) A technical description of the items being offered in sufficient detail to evaluate compliance with the requirements in the solicitation. This may include product literature, or other documents, if necessary;

(5) Terms of any express warranty;

(6) Price and any discount terms;

(7) "Remit to" address, if different than mailing address;

(8) A completed copy of the representations and certifications at FAR 52.212-3 (see FAR 52.212-3(b) for those representations and certifications that the offeror shall complete electronically);

(9) Acknowledgment of Solicitation Amendments;

(10) Past performance information, when included as an evaluation factor, to include recent and relevant contracts for the same or similar items and other references (including contract numbers, points of contact with telephone numbers and other relevant information); and

(11) If the offer is not submitted on the SF 1449, include a statement specifying the extent of agreement with all terms, conditions, and provisions included in the solicitation. Offers that fail to furnish required representations or information or reject the terms and conditions of the solicitation may be excluded from consideration.

(c) Period for acceptance of offers. The offeror agrees to hold the prices in its offer firm for 30 calendar days from the date specified for receipt of offers, unless another time period is specified in an addendum to the solicitation.

(d) Product samples. When required by the solicitation, product samples shall be submitted at or prior to the time specified for receipt of offers. Unless otherwise specified in this solicitation, these samples shall be submitted at no expense to the Government, and returned at the sender's request and expense, unless they are destroyed during preaward testing.

(e) Multiple offers. Offerors are encouraged to submit multiple offers presenting alternative terms and conditions, including alternative line items (provided that the alternative line items are consistent with subpart 4.10 of the Federal Acquisition Regulation), or alternative commercial items for satisfying the requirements of this solicitation. Each offer submitted will be evaluated separately.

(f) Late submissions, modifications, revisions, and withdrawals of offers.

(1) Offerors are responsible for submitting offers, and any modifications, revisions, or withdrawals, so as to reach the Government office designated in the solicitation by the time specified in the solicitation. If no time is specified in the solicitation, the time for receipt is 4:30 p.m., local time, for the designated Government office on the date that offers or revisions are due.

(2)(i) Any offer, modification, revision, or withdrawal of an offer received at the Government office designated in the solicitation after the exact time specified for receipt of offers is "late" and will not be considered unless it is received before award is made, the Contracting Officer determines that accepting the late offer would not unduly delay the acquisition; and

(A) If it was transmitted through an electronic commerce method authorized by the solicitation, it was received at the initial point of entry to the Government infrastructure not later than 5:00 p.m. one working day prior to the date specified for receipt of offers; or

(B) There is acceptable evidence to establish that it was received at the Government installation designated for receipt of offers and was under the Government's control prior to the time set for receipt of offers; or

(C) If this solicitation is a request for proposals, it was the only proposal received.

(ii) However, a late modification of an otherwise successful offer, that makes its terms more favorable to the Government, will be considered at any time it is received and may be accepted.

(3) Acceptable evidence to establish the time of receipt at the Government installation includes the time/date stamp of that installation on the offer wrapper, other documentary evidence of receipt maintained by the installation, or oral testimony or statements of Government personnel.

(4) If an emergency or unanticipated event interrupts normal Government processes so that offers cannot be received at the Government office designated for receipt of offers by the exact time specified in the solicitation, and urgent Government requirements preclude amendment of the solicitation or other notice of an extension of the closing date, the time specified for receipt of offers will be deemed to be extended to the same time of day specified in the solicitation on the first work day on which normal Government processes resume.

(5) Offers may be withdrawn by written notice received at any time before the exact time set for receipt of offers. Oral offers in response to oral solicitations may be withdrawn orally. If the solicitation authorizes facsimile offers, offers may be withdrawn via facsimile received at any time before the exact time set for receipt of offers, subject to the conditions specified in the solicitation concerning facsimile offers. An offer may be withdrawn in person by an offeror or its authorized representative if, before the exact time set for receipt of offers, the identity of the person requesting withdrawal is established and the person signs a receipt for the offer.

(g) Contract award (not applicable to Invitation for Bids). The Government intends to evaluate offers and award a contract without discussions with offerors. Therefore, the offeror's initial offer should contain the offeror's best terms from a price and technical standpoint. However, the Government reserves the right to conduct discussions if later determined by the Contracting Officer to be necessary. The Government may reject any or all offers if such action is in the public interest; accept other than the lowest offer; and waive informalities and minor irregularities in offers received.

(h) Multiple awards. The Government may accept any item or group of items of an offer, unless the offeror qualifies the offer by specific limitations. Unless otherwise provided in the Schedule, offers may not be submitted for quantities less than those specified. The Government reserves the right to make an award on any item for a quantity less than the quantity offered, at the unit prices offered, unless the offeror specifies otherwise in the offer.

(i) Availability of requirements documents cited in the solicitation.

(1)(i) The GSA Index of Federal Specifications, Standards and Commercial Item Descriptions, FPMR Part 101-29, and copies of specifications, standards, and commercial item descriptions cited in this solicitation may be obtained for a fee by submitting a request to

GSA Federal Supply Service Specifications Section

Suite 8100 470 East L'Enfant Plaza, SW

Washington, DC 20407

Telephone (202) 619-8925

Facsimile (202) 619-8978.

(ii) If the General Services Administration, Department of Agriculture, or Department of Veterans Affairs issued this solicitation, a single copy of specifications, standards, and commercial item descriptions cited in this solicitation may be obtained free of charge by submitting a request to the addressee in paragraph (i)(1)(i) of this provision. Additional copies will be issued for a fee.

(2) Most unclassified Defense specifications and standards may be downloaded from the following ASSIST websites:

(i) ASSIST (https://assist.dla.mil/online/start/);

(ii) Quick Search (http://quicksearch.dla.mil/);

(iii) ASSISTdocs.com (http://assistdocs.com).

(3) Documents not available from ASSIST may be ordered from the Department of Defense Single Stock Point (DoDSSP) by?

(i) Using the ASSIST Shopping Wizard (https://assist.dla.mil/wizard/index.cfm);

(ii) Phoning the DoDSSP Customer Service Desk (215) 697-2179, Mon-Fri, 0730 to 1600 EST; or

(iii) Ordering from DoDSSP, Building 4, Section D, 700 Robbins Avenue, Philadelphia, PA 19111-5094, Telephone (215) 697-2667/2179, Facsimile (215) 697-1462.

(4) Nongovernment (voluntary) standards must be obtained from the organization responsible for their preparation, publication, or maintenance.

(j) Unique entity identifier. (Applies to all offers exceeding $10,000 and offers of $10,000 or less if the solicitation requires the Contractor to be registered in the System for Award Management (SAM).) The Offeror shall enter, in the block with its name and address on the cover page of its offer, the annotation Unique Entity Identifier followed by the unique entity identifier that identifies the Offeror s name and address. The Offeror also shall enter its Electronic Funds Transfer (EFT) indicator, if applicable. The EFT indicator is a four-character suffix to the unique entity identifier. The suffix is assigned at the discretion of the Offeror to establish additional SAM records for identifying alternative EFT accounts (see subpart 32.11) for the same entity. If the Offeror does not have a unique entity identifier, it should contact the entity designated at www.sam.gov for unique entity identifier establishment directly to obtain one. The Offeror should indicate that it is an offeror for a Government contract when contacting the entity designated at www.sam.gov for establishing the unique entity identifier.

(k) [Reserved]

(l) Debriefing. If a post-award debriefing is given to requesting offerors, the Government shall disclose the following information, if applicable:

(1) The agency's evaluation of the significant weak or deficient factors in the debriefed offeror's offer.

(2) The overall evaluated cost or price and technical rating of the successful and the debriefed offeror and past performance information on the debriefed offeror.

(3) The overall ranking of all offerors, when any ranking was developed by the agency during source selection.

(4) A summary of the rationale for award;

(5) For acquisitions of commercial items, the make and model of the item to be delivered by the successful offeror.

(6) Reasonable responses to relevant questions posed by the debriefed offeror as to whether source-selection procedures set forth in the solicitation, applicable regulations, and other applicable authorities were followed by the agency.

(End of Provision)

ADDENDUM to FAR 52.212-1 INSTRUCTIONS TO OFFERORS COMMERCIAL ITEMS

Provisions that are incorporated by reference (by Citation Number, Title, and Date), have the same force and effect as if they were given in full text. Upon request, the Contracting Officer will make their full text available.

The following provisions are incorporated into 52.212-1 as an addendum to this solicitation:

(End of Addendum to 52.212-1)

Submission of your response shall be received not later than 09/15/2021 at 6AM PST to adrienne.brown4@va.gov.

Late submissions shall be treated in accordance with the solicitation provision at FAR 52.212-1(f).

Any questions or concerns regarding this solicitation should be forwarded in writing via e-mail to the Point of Contact listed below.

Point of Contact

Adrienne Brown, Contract Specialist

adrienne.brown4@va.gov

See attached document: P01 LB SOW 2021 Compounding Chemotherapy Meds.

Files

File Type Posted
P01 - Salient Characteristics.docx DOCX document
36C26221Q1279.docx DOCX document
P01 - SOW 2022 Compounding Chemotherapy Meds.docx DOCX document

Similar open opportunities

Opportunity Agency Set-aside Responses due
6505--FY27 Low Energy General Radiopharmaceuticals 36C25027Q0052 See Section 11 of the Cleveland and Kent, Ohio, United States · NAICS 325412 Veterans Integrated Service Network 10 No set-aside
6835-- BULK OXYGEN (Base+4 Option) Department of Veterans Affairs Long Beach Healthcare System Long Beach, California 90822, United States · NAICS 325120 Veterans Integrated Service Network 22 Service-Disabled Veteran-Owned Small Business
6505--Imatinib Tablets NAICS 325412 National Acquisition Center No set-aside

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity